RDNT
RadNet, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$76.00
−2.29%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- $0.21
- Revenue estimate
- $640.0M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- $0.29
- EPS estimate
- $0.20
- Revenue actual
- $622.7M
- Revenue estimate
- $610.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +7.6%
- Revenue beats (12Q)
- 6
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $87
- PT range
- $79 – $94
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | $0.20 | $0.29 | Beat 43.99% | $622.7M |
| May 11, 2026 | -$0.14 | -$0.28 | Miss -100.00% | $575.6M |
| Feb 27, 2025 | $0.21 | $0.22 | Beat 4.76% | $477.1M |
| Feb 29, 2024 | $0.11 | $0.20 | Beat 81.82% | $420.4M |
| Nov 8, 2023 | $0.06 | $0.14 | Beat 133.33% | $402.0M |
| Feb 28, 2023 | $0.15 | $0.11 | Miss -26.67% | $383.9M |
| Nov 9, 2022 | $0.16 | $0.09 | Miss -43.75% | $350.0M |
| Mar 1, 2022 | $0.19 | $0.13 | Miss -31.58% | $333.1M |
| Mar 8, 2021 | $0.16 | $0.20 | Beat 25.00% | $308.5M |
| Mar 12, 2020 | $0.15 | $0.21 | Beat 40.00% | $300.8M |
| Nov 12, 2019 | $0.11 | $0.06 | Miss -45.45% | $292.7M |
| Aug 8, 2019 | $0.12 | $0.10 | Miss -16.67% | $289.1M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026